Perimenopause uncertainty is prevalent among 34 percent of women aged 35 years or older, according to a study.

The FDA has accepted Camurus' resubmitted NDA for CAM2029 (octreotide) extended-release injection for acromegaly, setting a PDUFA date of December 18, 2026.

Millions of people are breathing dangerous air this week as heavy smoke from wildfires in Canada and Minnesota spreads across the region.

Consistent resistance training during midlife combined with aerobic activity may lower the risk for type 2 diabetes in adults.

A recent study explores how anti-Mullerian hormone levels can rebound after falling below detection limits during menopause.

Bariatric surgery may increase the risk for alcohol problems, according to 2 studies that were recently published.

As the aging population grows, a need increases for NPs to screen for common geriatric syndromes during routine primary care ...

The ACC has issued a 2026 scientific statement on the use of direct oral anticoagulants (DOACs) for the prevention of thrombotic events.

Sleeve gastrectomy may offer greater weight loss and glycemic control than semaglutide or tirzepatide in adults with obesity and T2D.

A nationwide cohort study examines the oncologic safety of GLP-1 receptor agonists in patients with endogenous Cushing syndrome.

The ACC has released a 2026 scientific statement addressing antiplatelet therapy in atherosclerotic cardiovascular disease (ASCVD).

Health care professional shortages and limited access to pharmacies are substantial barriers to BP management in rural areas.